AbbVie Inc. (ABBV)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 161.24 |
| Open | 160.00 |
| Bid | 159.76 x 800 |
| Ask | 160.26 x 1200 |
| Day's range | 158.83 - 163.19 |
| 52-week range | 130.96 - 182.89 |
| Volume | |
| Avg. volume | 5,783,638 |
| Market cap | 282.875B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 47.82 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.20 (3.85%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | N/A |
- Zacks
AbbVie (ABBV) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
- Zacks
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
AbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing seeking label expansion for the immunology drug, Skyrizi, to treat UC.
- Zacks
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
AbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.